Marimed (MRMD) Restructuring Costs (2022 - 2026)

Marimed (MRMD) has 5 years of Restructuring Costs data on file, last reported at $169000.0 in Q1 2026.

• On a quarterly basis, Restructuring Costs rose 50.89% year-over-year to $169000.0 in Q1 2026; TTM through Mar 2026 was $543000.0, a 44.54% decrease from a year earlier, with the FY2025 full-year figure at $486000.0, down 48.9% from the prior year.
• Restructuring Costs for Q1 2026 stood at $169000.0, up from $90000.0 in the prior quarter.
• Over the last five years, Restructuring Costs for MRMD reached as high as $754000.0 in Q2 2022 and fell as low as $32000.0 in Q3 2023.
• Historically, Restructuring Costs has averaged $203875.0 across 5 years, with a median of $144000.0 in 2022.
• Across the five-year window, Restructuring Costs slumped 77.62% in 2023 and jumped 1059.38% in 2024, its largest moves.
• Year by year, Restructuring Costs stood at $64000.0 in 2022, then slipped by 25.0% to $48000.0 in 2023, then jumped by 204.17% to $146000.0 in 2024, then tumbled by 38.36% to $90000.0 in 2025, then jumped by 87.78% to $169000.0 in 2026.
• Per Business Quant data, the three most recent Restructuring Costs figures were $169000.0 in Q1 2026, $90000.0 in Q4 2025, and $145000.0 in Q3 2025.